The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Engineered, fully human nanobody-based CAR T cells have enhanced antitumor activity against hepatocellular carcinoma in preclinical models.
 
Aarti Kolluri
Patents, Royalties, Other Intellectual Property - NIH/NCI (Inst)
 
Dan Li
No Relationships to Disclose
 
Nan Li
Patents, Royalties, Other Intellectual Property - NIH/NCI (Inst)
 
Mitchell Ho
Research Funding - crispr therapeutics (Inst); Cytovia Therapeutics (Inst); NeoImmuneTech (Inst); Xyphos (Inst)
Patents, Royalties, Other Intellectual Property - Patents related to antibodies, CAR-T, and other therapeutics targeting GPC3, GPC2, GPC1, mesothelin, B7-H3, PD-L1, SARS-CoV-2, and Lassa. (Inst)